评价-话题@MedSci

#评价#

750篇内容 | 3012人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1444672, encodeId=273c14446e205, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=第3家！齐鲁「注射用头孢曲松钠」通过一致性评价, objectType=article, longId=205715, objectId=f73c205e1576, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f73c205e1576, replyNumber=0, likeNumber=84, createdTime=2021-01-15, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f73c205e1576, moduleTitle=第3家！齐鲁「注射用头孢曲松钠」通过一致性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f73c205e1576)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444671, encodeId=d12d14446e132, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=国家药监批准多款首仿、首家通过一致性评价药品, objectType=article, longId=205476, objectId=e1942054e6ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1942054e6ff, replyNumber=0, likeNumber=69, createdTime=2021-01-09, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1942054e6ff, moduleTitle=国家药监批准多款首仿、首家通过一致性评价药品, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1942054e6ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444670, encodeId=4d5514446e046, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Lancet子刊 | 宁光院士团队：系统评价我国2型糖尿病随机对照试验, objectType=article, longId=205401, objectId=3c1420540120, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c1420540120, replyNumber=0, likeNumber=81, createdTime=2021-01-08, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c1420540120, moduleTitle=Lancet子刊 | 宁光院士团队：系统评价我国2型糖尿病随机对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c1420540120)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444669, encodeId=b05c144466930, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=新版三级医院评价标准发布，DRG成核心评价体系, objectType=article, longId=205321, objectId=8ad72053211c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ad72053211c, replyNumber=0, likeNumber=97, createdTime=2021-01-06, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ad72053211c, moduleTitle=新版三级医院评价标准发布，DRG成核心评价体系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ad72053211c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444668, encodeId=9553144466809, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Heart：重新评价NYHA I级和II级心力衰竭, objectType=article, longId=205273, objectId=f1682052e3e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1682052e3e2, replyNumber=0, likeNumber=0, createdTime=2021-01-05, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1682052e3e2, moduleTitle=Heart：重新评价NYHA I级和II级心力衰竭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1682052e3e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444667, encodeId=c821144466ef2, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=国家卫生健康委：到2022年底基本建立医养结合服务质量标准和评价体系, objectType=article, longId=205254, objectId=4e70205254ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e70205254ae, replyNumber=0, likeNumber=66, createdTime=2021-01-04, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e70205254ae, moduleTitle=国家卫生健康委：到2022年底基本建立医养结合服务质量标准和评价体系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e70205254ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444666, encodeId=ef2114446662c, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=LETS 2020｜蒋俊豪：目前血管准备评价标准的方法是否合理？, objectType=article, longId=205050, objectId=c7e32050501d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7e32050501d, replyNumber=0, likeNumber=80, createdTime=2021-01-01, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7e32050501d, moduleTitle=LETS 2020｜蒋俊豪：目前血管准备评价标准的方法是否合理？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7e32050501d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444665, encodeId=8ba214446657f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=真实世界证据可用于11种常见情形医疗器械临床评价, objectType=article, longId=204238, objectId=7300204238bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7300204238bf, replyNumber=0, likeNumber=77, createdTime=2020-12-08, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7300204238bf, moduleTitle=真实世界证据可用于11种常见情形医疗器械临床评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7300204238bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444664, encodeId=60fd144466491, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=CLIN CHEM LAB MED：生物素干扰：新一代电化学发光免疫分析法检测高灵敏度肌钙蛋白T和促甲状腺激素的评价, objectType=article, longId=203923, objectId=fe5c2039233b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe5c2039233b, replyNumber=0, likeNumber=110, createdTime=2020-12-02, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe5c2039233b, moduleTitle=CLIN CHEM LAB MED：生物素干扰：新一代电化学发光免疫分析法检测高灵敏度肌钙蛋白T和促甲状腺激素的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe5c2039233b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444663, encodeId=ab5714446632d, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Nat Commun：急性心肌梗死和致命性冠心病相关饮食因素的系统综合纵向评价, objectType=article, longId=203837, objectId=a40c20383eb7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a40c20383eb7, replyNumber=0, likeNumber=77, createdTime=2020-11-30, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a40c20383eb7, moduleTitle=Nat Commun：急性心肌梗死和致命性冠心病相关饮食因素的系统综合纵向评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a40c20383eb7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444662, encodeId=0ec31444662b4, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=国家药监局发布，真实世界数据用于医疗器械临床评价技术指导原则（试行）, objectType=article, longId=203785, objectId=9f30203e8509, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f30203e8509, replyNumber=0, likeNumber=74, createdTime=2020-11-28, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f30203e8509, moduleTitle=国家药监局发布，真实世界数据用于医疗器械临床评价技术指导原则（试行）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f30203e8509)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444661, encodeId=db7914446610c, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=JNNP: 成人功能性神经障碍心理治疗的系统评价, objectType=article, longId=203656, objectId=3e0320365601, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e0320365601, replyNumber=0, likeNumber=68, createdTime=2020-11-24, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e0320365601, moduleTitle=JNNP: 成人功能性神经障碍心理治疗的系统评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e0320365601)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444660, encodeId=22581444660a9, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=宜昌人福「盐酸安非他酮缓释片」首家通过一致性评价, objectType=article, longId=203621, objectId=861f2036212d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=861f2036212d, replyNumber=0, likeNumber=81, createdTime=2020-11-23, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=861f2036212d, moduleTitle=宜昌人福「盐酸安非他酮缓释片」首家通过一致性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=861f2036212d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444659, encodeId=15da1444659ed, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=8款仿制药通过一致性评价！2款为首家过评，3款为第2家过评, objectType=article, longId=202910, objectId=02ac20291093, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02ac20291093, replyNumber=0, likeNumber=88, createdTime=2020-11-06, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02ac20291093, moduleTitle=8款仿制药通过一致性评价！2款为首家过评，3款为第2家过评, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02ac20291093)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444658, encodeId=8e201444658a2, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=7款仿制药通过一致性评价！2款注射剂为国内首家, objectType=article, longId=202873, objectId=8aa42028e353, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8aa42028e353, replyNumber=0, likeNumber=61, createdTime=2020-11-05, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8aa42028e353, moduleTitle=7款仿制药通过一致性评价！2款注射剂为国内首家, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8aa42028e353)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444657, encodeId=887f144465ed4, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=决策曲线分析法用于评价疾病风险模型, objectType=article, longId=202427, objectId=56c420242eb4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56c420242eb4, replyNumber=0, likeNumber=68, createdTime=2020-10-25, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56c420242eb4, moduleTitle=决策曲线分析法用于评价疾病风险模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56c420242eb4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444656, encodeId=e37c144465612, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=14款仿制药通过一致性评价，来自正大天晴、福元医药…, objectType=article, longId=202329, objectId=d9f92023292c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9f92023292c, replyNumber=0, likeNumber=73, createdTime=2020-10-22, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9f92023292c, moduleTitle=14款仿制药通过一致性评价，来自正大天晴、福元医药…, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9f92023292c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444655, encodeId=f4251444655e2, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=FINTEPLA（芬氟拉明）治疗Dravet综合征的癫痫发作：CHMP持正面评价, objectType=article, longId=202237, objectId=0af120223ece, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0af120223ece, replyNumber=0, likeNumber=77, createdTime=2020-10-19, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0af120223ece, moduleTitle=FINTEPLA（芬氟拉明）治疗Dravet综合征的癫痫发作：CHMP持正面评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0af120223ece)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444654, encodeId=2ad114446544f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=降脂神药！一年给药2次，药效持续17个月，诺华的siPCSK9疗法inclisiran获得欧洲CHMP的正面评价, objectType=article, longId=202221, objectId=a2c720222179, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2c720222179, replyNumber=0, likeNumber=64, createdTime=2020-10-18, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2c720222179, moduleTitle=降脂神药！一年给药2次，药效持续17个月，诺华的siPCSK9疗法inclisiran获得欧洲CHMP的正面评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2c720222179)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444653, encodeId=e116144465367, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=高磷血症药！百美特生物「醋酸钙片」首家通过一致性评价, objectType=article, longId=202181, objectId=a7c6202181f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7c6202181f3, replyNumber=0, likeNumber=73, createdTime=2020-10-17, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7c6202181f3, moduleTitle=高磷血症药！百美特生物「醋酸钙片」首家通过一致性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7c6202181f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

评价

2020-05-29

huagfeg (审核中...)

前往app查看评论内容

#评价#

第3家！齐鲁「注射用头孢曲松钠」通过一致性评价

2021-01-15

huagfeg (审核中...)

前往app查看评论内容

#评价#

国家药监批准多款首仿、首家通过一致性评价药品

2021-01-09

huagfeg (审核中...)

前往app查看评论内容

#评价#

Lancet子刊 | 宁光院士团队：系统评价我国2型糖尿病随机对照试验

2021-01-08

huagfeg (审核中...)

前往app查看评论内容

#评价#

新版三级医院评价标准发布，DRG成核心评价体系

2021-01-06

huagfeg (审核中...)

前往app查看评论内容

#评价#

Heart：重新评价NYHA I级和II级心力衰竭

2021-01-05

huagfeg (审核中...)

前往app查看评论内容

#评价#

国家卫生健康委：到2022年底基本建立医养结合服务质量标准和评价体系

2021-01-04

huagfeg (审核中...)

前往app查看评论内容

#评价#

LETS 2020｜蒋俊豪：目前血管准备评价标准的方法是否合理？

2021-01-01

huagfeg (审核中...)

前往app查看评论内容

#评价#

真实世界证据可用于11种常见情形医疗器械临床评价

2020-12-08

huagfeg (审核中...)

前往app查看评论内容

#评价#

CLIN CHEM LAB MED：生物素干扰：新一代电化学发光免疫分析法检测高灵敏度肌钙蛋白T和促甲状腺激素的评价

2020-12-02

huagfeg (审核中...)

前往app查看评论内容

#评价#

Nat Commun：急性心肌梗死和致命性冠心病相关饮食因素的系统综合纵向评价

2020-11-30

huagfeg (审核中...)

前往app查看评论内容

#评价#

国家药监局发布，真实世界数据用于医疗器械临床评价技术指导原则（试行）

2020-11-28

huagfeg (审核中...)

前往app查看评论内容

#评价#

JNNP: 成人功能性神经障碍心理治疗的系统评价

2020-11-24

huagfeg (审核中...)

前往app查看评论内容

#评价#

宜昌人福「盐酸安非他酮缓释片」首家通过一致性评价

2020-11-23

huagfeg (审核中...)

前往app查看评论内容

#评价#

8款仿制药通过一致性评价！2款为首家过评，3款为第2家过评

2020-11-06

huagfeg (审核中...)

前往app查看评论内容

#评价#

7款仿制药通过一致性评价！2款注射剂为国内首家

2020-11-05

huagfeg (审核中...)

前往app查看评论内容

#评价#

决策曲线分析法用于评价疾病风险模型

2020-10-25

huagfeg (审核中...)

前往app查看评论内容

#评价#

14款仿制药通过一致性评价，来自正大天晴、福元医药…

2020-10-22

huagfeg (审核中...)

前往app查看评论内容

#评价#

FINTEPLA（芬氟拉明）治疗Dravet综合征的癫痫发作：CHMP持正面评价

2020-10-19

huagfeg (审核中...)

前往app查看评论内容

#评价#

降脂神药！一年给药2次，药效持续17个月，诺华的siPCSK9疗法inclisiran获得欧洲CHMP的正面评价

2020-10-18

huagfeg (审核中...)

前往app查看评论内容

#评价#

高磷血症药！百美特生物「醋酸钙片」首家通过一致性评价

2020-10-17

科室
- - 订阅+
  - 更多科室
工具
服务